Margherita Ghisi

99 Commercial Rd
Melbourne, VIC 3004, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

AMPK activation induces immunogenic cell death in AML.

AMPK activation induces immunogenic cell death in AML.

Journal: Blood advances

Published: November 29, 2022

Acute myeloid leukemia maturation lineage influences residual disease and relapse following differentiation therapy.

Acute myeloid leukemia maturation lineage influences residual disease and relapse following differentiation therapy.

Journal: Nature communications

Published: March 03, 2021

Extracellular ATP and CD39 Activate cAMP-Mediated Mitochondrial Stress Response to Promote Cytarabine Resistance in Acute Myeloid Leukemia.

Extracellular ATP and CD39 Activate cAMP-Mediated Mitochondrial Stress Response to Promote Cytarabine Resistance in Acute Myeloid Leukemia.

Journal: Cancer discovery

Published: August 30, 2019

Interconversion between Tumorigenic and Differentiated States in Acute Myeloid Leukemia.

Interconversion between Tumorigenic and Differentiated States in Acute Myeloid Leukemia.

Journal: Cell stem cell

Published: June 25, 2018

Histone deacetylase 6 controls Notch3 trafficking and degradation in T-cell acute lymphoblastic leukemia cells.

Histone deacetylase 6 controls Notch3 trafficking and degradation in T-cell acute lymphoblastic leukemia cells.

Journal: Oncogene

Published: August 07, 2017

Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics.

Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics.

Journal: Cancer cell

Published: September 14, 2016

Functional interdependence of BRD4 and DOT1L in MLL leukemia.

Functional interdependence of BRD4 and DOT1L in MLL leukemia.

Journal: Nature structural & molecular biology

Published: March 14, 2016

Conserved IKAROS-regulated genes associated with B-progenitor acute lymphoblastic leukemia outcome.

Conserved IKAROS-regulated genes associated with B-progenitor acute lymphoblastic leukemia outcome.

Journal: The Journal of experimental medicine

Published: January 12, 2016

The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia.

The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia.

Journal: Science translational medicine

Published: August 26, 2015

Id2 and E Proteins Orchestrate the Initiation and Maintenance of MLL-Rearranged Acute Myeloid Leukemia.

Id2 and E Proteins Orchestrate the Initiation and Maintenance of MLL-Rearranged Acute Myeloid Leukemia.

Journal: Cancer cell

Published: July 11, 2015

Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics.

Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics.

Journal: Cancer cell

Published: April 08, 2015

Id2 represses E2A-mediated activation of IL-10 expression in T cells.

Id2 represses E2A-mediated activation of IL-10 expression in T cells.

Journal: Blood

Published: April 12, 2014

Showing 1-12 of 13

Last Updated: 09/26/2026